Irace, C., Casciaro, F., Scavelli, F. B., Oliverio, R., Cutruzzolà, A., Cortese, C., & Gnasso, A. (2018). Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. Cardiovasc Diabetol.
Chicago Style citaatIrace, Concetta, Francesco Casciaro, Faustina Barbara Scavelli, Rosa Oliverio, Antonio Cutruzzolà, Claudio Cortese, en Agostino Gnasso. "Empagliflozin Influences Blood Viscosity and Wall Shear Stress in Subjects With Type 2 Diabetes Mellitus Compared With Incretin-based Therapy." Cardiovasc Diabetol 2018.
MLA citatieIrace, Concetta, et al. "Empagliflozin Influences Blood Viscosity and Wall Shear Stress in Subjects With Type 2 Diabetes Mellitus Compared With Incretin-based Therapy." Cardiovasc Diabetol 2018.